Kidney Protective Jacket to keep donated kidneys cool during transplant
Official title: The Effect of Intraoperative Thermal Kidney Insulation on Current Kidney Transplantation Surgical Practices
Run by iiShield · NCT07348458 · Data updated 2026-11-12
This project will test a device called the Kidney Protective Jacket to help keep donated kidneys cooler during implantation for adults having their first or second kidney transplant.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | iiShield Industry-sponsored |
| Locations | 1 site (Westmead, New South Wales) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | June 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 25, 2026 |
| Trial ID | NCT07348458 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older receiving their first or second kidney transplant from a suitable deceased or living donor who can provide informed consent are the intended participants.
✕Probably not a fit
Patients receiving pediatric donor kidneys (donors under 16), those with a known silicone allergy, and recipients beyond a second transplant are excluded and therefore unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a safety-focused interventional study using the Kidney Protective Jacket (KPJ) during kidney transplantation to limit re-warming of the organ during the anastomosis phase. The device is applied to donated kidneys removed from cold storage and is intended to reduce second warm ischemic time-related temperature rise that contributes to ischemia-reperfusion injury. The study will include suitable deceased and living donor kidneys transplanted into consenting adults (age ≥18) undergoing their first or second transplant, with exclusions for pediatric donor kidneys and silicone allergy. Investigators aim to use the device across a range of anatomical and procedural scenarios (single/multiple renal vessels, varying kidney sizes and recipient body sizes) to document safety in typical clinical practice.
Why it matters
Potential benefit: If safe and effective at limiting kidney re-warming, the device could reduce ischemia-reperfusion injury and improve early graft function and outcomes after transplant.
How similar studies have gone: Previous research has shown that keeping kidneys cooler during implantation can reduce temperature rise and related injury, but the Kidney Protective Jacket itself is a novel device with limited prior clinical data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All deceased and living donor kidneys that are deemed suitable for transplantation * All suitable recipients who are 18 years or greater, and undergoing their first or second kidney transplant * All recipients must be able to provide full informed consent Exclusion Criteria: * Paediatric donor kidneys (kidneys from donors \< 16 years in age) * Patients with a known allergy or hypersensitivity to silicone
Where it's running
-
Westmead Hospital
Westmead, New South Wales, Australia Recruiting
Study contacts
- Study coordinator: Amy Hort, MBBS (HONS), MS, FRACS
- Email: amy.hort@health.nsw.gov.au
- Phone: +61432782850
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Omnisol-preserved kidneys before transplant (hypothermic machine perfusion)
This study tests whether using Omnisol during hypothermic machine perfusion before kidney transplant can improve early graft function compared with standard preservation.
-
How Propofol and Sevoflurane Affect miRNA in Living Kidney Donors
This study tests whether using propofol or sevoflurane during donor nephrectomy changes levels of miRNAs in living kidney donors.
-
Effects of general vs spinal-epidural anesthesia on kidney transplant biomarkers
This study tests whether sevoflurane general anesthesia or combined spinal-epidural anesthesia changes markers of cellular stress and protective peptides in adults undergoing kidney transplantation.
-
How kidney transplant patients feel about using artificial intelligence in medicine
This international survey asks adults who have had a kidney transplant how they feel about AI tools that predict graft loss and what it might mean for their daily care.
-
Personalized therapeutic stories for children after kidney transplant.
We will test whether clinician-supervised AI can create age-appropriate, personalized therapeutic stories for children aged 5–12 who have received a kidney transplant and their families.
-
Treating blood vessel problems after a kidney transplant
This effort will try catheter-based angioplasty and advanced imaging to see if they help kidney transplant recipients with graft dysfunction or stubborn high blood pressure from possible transplant blood‑vessel problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.